CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-24 | Heyman Richard A. Director | Sale 10b5-1 | −7,000 | $12.02 | $84K | 38,300 |
| 2026-07-24 | Heyman Richard A. Director | Sale 10b5-1 | −6,100 | $12.02 | $73K | 206,672 |
| 2026-07-24 | Heyman Richard A. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,500 | 30,200 | ||
| 2026-07-06 | Heyman Richard A. Director | Sale 10b5-1 | −300 | $12.00 | $4K | 212,772 |
| 2026-02-24 | Piscitelli Dominic Chief Financial Officer | Option exercise 10b5-1 | +52,000 | $4.36 | $227K | 120,148 |
| 2026-02-24 | Piscitelli Dominic Chief Financial Officer | Sale 10b5-1 | −52,000 | $13.51 | $703K | 68,148 |
| 2026-02-24 | Piscitelli Dominic Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −52,000 | 144,500 | ||
| 2026-01-16 | Heyman Richard A. Director | Sale 10b5-1 | −3,500 | $12.00 | $42K | 41,800 |
| 2026-01-16 | Heyman Richard A. Director | Sale 10b5-1 | −3,200 | $12.00 | $38K | 213,072 |
| 2026-01-02 | Piscitelli Dominic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +206,500 | 206,500 | ||
| 2026-01-02 | Piscitelli Dominic Chief Financial Officer | Grant or award · Restricted Stock Unit | +34,500 | 34,500 | ||
| 2026-01-02 | You Angie Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Chacko Jacob PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +675,000 | 675,000 | ||
| 2026-01-02 | Chacko Jacob PRESIDENT AND CEO | Grant or award · Restricted Stock Unit | +112,500 | 112,500 | ||
| 2026-01-02 | Multani Pratik S Chief Medical Officer | Grant or award · Stock Option (right to buy) | +214,000 | 214,000 | ||
| 2026-01-02 | Multani Pratik S Chief Medical Officer | Grant or award · Restricted Stock Unit | +35,500 | 35,500 | ||
| 2026-01-02 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Dier Mardi Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Kunkel Lori Anne Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Hoerter Steven L. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 2 of 12 · 228 trades